Clinical communication and collaboration software vendor Perfect Serve hopes it aces M & A, acquiring two firms, one is Lightning Bolt which does physician shift scheduling, and the other is CareWire, which does text messaging for patient engagement.
https://medcitynews.com/2019/02/perfectserve-acquires/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=69644103&_hsenc=p2ANqtz-_mA-3zRDFNPg8CWTNmmnjvpBMIbqtbi0pPi7M67WeZuBgc_iNzYBVAatKHO0CJjrJX-BkKbxagxyNtG6m9D0F65Smlpabfku1YVHFzaiHva4Mvx4g&_hsmi=69644103A new study discusses trends in private equity firms buying physician practices.
Read More
A research letter in JAMA Internal Medicine discusses physicians perspectives on FDA expedited drug approval pathways.
Read More
A research letter in JAMA Internal Medicine describes consumer reactions to drug pricing disclosure.
Read More
A report from PriceWaterhouse Cooper evaluates the year that was in health care M & A.
Read More
Population health, disease management, digital health, mobile app, (and any other buzzword) firm Livongo is acquiring myStrength, a behavioral health firm with the same buzzwords, for an undisclosed, but hopefully weak, amount.
https://www.fiercebiotech.com/medtech/livongo-dives-into-behavioral-health-mystrength-buy?mkt_tok=eyJpIjoiTVRrMk9UUTVOekEzTkdJNSIsInQiOiJialJHQTF4Wng3Q2JGMXkyTWViVDdFajl6REFUcmNvV1pVemM0RHZ3MkhZTnJRcERiZEl4OG5SdWdmZTlPdTNoOFUyWkVaZXpab1oxVmRPdFB2SVNPZEFPbTF5aHBwQUZ1TEJNcHdZU0loRjR0M0s3U0E2S1lUUXRQU1wvcnJmeHgifQ%3D%3D&mrkid=635530&utm_medium=nl&utm_source=internalEBSCO Health, part of a large multi-industry information firm, is buying Health Decision, a clinical support vendor.
https://medcitynews.com/2019/01/ebsco-health-healthdecision/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=69348244&_hsenc=p2ANqtz-9onAPVvakGAfiov0KapC2rYbr2mYl0kynNC-3ELtJysfhjszSWlZjr-RhsjOnKmRumvakyx9xxOl5kSdbm6L-53y4but3442JUoFsTxYYkgXAqJyc&_hsmi=69348244&rf=1A report from IQVIA covers expected spending and trends in global drug use over the next few years.
Read More